| 000 | 00934 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514025839.0 | ||
| 264 | 0 | _c20020424 | |
| 008 | 200204s 0 0 fin d | ||
| 022 | _a0012-7183 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToivonen, M | |
| 245 | 0 | 0 |
_a[The safety of sildenafil]. _h[electronic resource] |
| 260 |
_bDuodecim; laaketieteellinen aikakauskirja _c1999 |
||
| 300 |
_a1482-3 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAccess to Information |
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstatistics & numerical data |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 | _aPurines |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 | _aSulfones |
| 773 | 0 |
_tDuodecim; laaketieteellinen aikakauskirja _gvol. 115 _gno. 14 _gp. 1482-3 |
|
| 999 |
_c11818037 _d11818037 |
||